In humans, a polymorphism predicted to reduce NKG2D signaling is linked to both increased cancer risk (Roszak et al., 2012) and susceptibility to viral infections (Taniguchi et al., 2015). This evidence concerns the gene KLRK1 and viral infectious disease.